<DOC>
	<DOCNO>NCT00777972</DOCNO>
	<brief_summary>The objective study compare relative bioavailability Fosinopril sodium hydrochlorothiazide 20-12.5 mg tablet Ranbaxy Laboratories Limited Monopril ®.-HCT 20-12.5 mg tablet Bristol-Meyers Squibb follow single oral dose ( 1 x 20-12.5 mg tablet ) healthy adult subject fasting condition</brief_summary>
	<brief_title>Bioequivalence Study Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description>This study single dose , randomize , two period , two treatment , two sequence crossover study design use evaluate relative bioavailability Fosinopril sodium hydrochlorothiazide tablet product dose ( 1 x 20-12.5 mg ) fasting condition . The two period study separate washout period least week . A total 36 healthy adult subject enrol study . Of subject 34 subject ( 21 male 13 female ) complete study .</detailed_description>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Fosinopril</mesh_term>
	<criteria>1 . Subjects least 18 year old 2 . Female subject negative serum pregnancy test 3 . Subject clinically significant abnormal lab value preentry evaluation 4 . Subjects negative nonreactive urine drug abuse , hepatitis B , hepatitis C HIV screen 5 . Subject acceptable ECG 6 . Subject evidence underlie disease preentry physical examination 7 . Subject agree undergo least 14 day washout period prescription drug prior first dose study throughout period blood sample collection 8 . Subject agree undergo least 7 day washout period OTC product , herbal medication , etc . prior first dose study medication throughout period blood sample collection 9 . Subject agree abstain consume alcohol least 48 hour prior dose throughout period blood sample obtain 10 . Subject agree abstain consume grapefruit , grapefruit juice , food contain grapefruit least 48 hour prior dose throughout period blood sample obtain 11 . Subject give write consent participate 1 . Subject history chronic alcohol consumption ( past 2 year ) drug addiction 2 . Subject history serious gastrointestinal , renal , hepatic cardiovascular disease , tuberculosis , epilepsy , asthma ( past 5 year ) , diabetes , psychosis glaucoma 3 . Subject history allergic response class drug test . 4 . Subject donate blood and/ plasma within last thirty ( 30 ) day prior first dose study 5 . Subject take investigational drug within thirty ( 30 ) day prior first dose study 6 . Female subject pregnant , breast feeding , likely come pregnant study . Female subject child bear potential must either abstain sexual intercourse use reliable barrier method ( eg condom , IUD ) contraception course study ( first dose last blood collection ) 7 . Female subject use implant injected hormonal contraceptive ( except Lunelle ® Monthly Injection ) anytime 6 month prior study dose , Lunelle ® Monthly Injection anytime 45 day prior study dose , use oral hormonal contraceptive within 14 day dose . 8 . Subject inability read and/ sign consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence Fosinopril sodium hydrochlorothiazide 20-12.5 mg tablet fast condition</keyword>
</DOC>